Indiana Center Helped Bring New Hemophilia Treatment To Light
By: Araceli Gómez-Aldana, Side Effects Public Media
There’s a new treatment now for thousands of patients in the U.S. who live with a rare disorder where blood doesn’t clot. The Food and Drug Administration recently approved Hemlibra, which is produced by Genentech, Inc.
Dr. Amy Shapiro is CEO of the Indiana Hemophilia and Thrombosis Center in Indianapolis.
After eight years of development, the center took part in a clinical trial that lead to the FDA approving the new treatment for patients with Hemophilia A.